Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiangzhininggan capsule in nonalcoholic simple fatty liver (phlegm-blood stasis pattern)
CTR20131783Phase 2Completed
- Sponsor
- Guangzhou Boda Pharmaceutical High-Tech Research Center
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jiangzhi Ninggan Capsule in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Guangzhou Boda Pharmaceutical High-Tech Research Center. Started Aug 2014; status: completed.
02
Drugs
Jiangzhi Ninggan Capsule
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on CTR20131783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131783.